LitAlert ~~ GeneLit.com

    • Whole-Genome Sequencing Identifies PPARGC1A as a Putative Modifier of Cancer Risk in BRCA1/2 Mutation Carriers.
    • Zhu Q, Wang J, Yu H, Hu Q, Bateman MW, Long M, Rosario S, Schultz E, Dalgard CL, Wilkerson MD, Sukumar G, Huang RY, Kaur J, Lele SB, Zsiros E, Villella J, Lugade A, Moysich K, Conrads TP, Maxwell GL, Odunsi K.
    • Cancers (Basel). 2022 May 10;14(10):2350. doi: 10.3390/cancers14102350.
    • Breast cancer during pregnancy: epidemiology, phenotypes, presentation during pregnancy and therapeutic modalities.
    • Boere I, Lok C, Poortmans P, Koppert L, Painter R, Heuvel-Eibrink MM, Amant F.
    • Best Pract Res Clin Obstet Gynaecol. 2022 May 9:S1521-6934(22)00078-5. doi: 10.1016/j.bpobgyn.2022.05.001. Epub ahead of print.
    • Does receiving high or low breast cancer risk estimates produce a reduction in subsequent breast cancer screening attendance? Cohort study.
    • French DP, McWilliams L, Howell A, Evans DG.
    • Breast. 2022 May 9:S0960-9776(22)00093-5. doi: 10.1016/j.breast.2022.05.001. Epub ahead of print.
    • The genetics of hereditary cancer risk syndromes in Brazil: a comprehensive analysis of 1682 patients.
    • de Oliveira JM, Zurro NB, Coelho AVC, Caraciolo MP, de Alexandre RB, Cervato MC, Minillo RM, de Vasconcelos Carvalho Neto G, Grivicich I, Oliveira JB.
    • Eur J Hum Genet. 2022 May 9. doi: 10.1038/s41431-022-01098-7. Epub ahead of print.
    • Germline pathogenic variants in unselected Korean men with prostate cancer.
    • So MK, Ahn HK, Huh J, Kim KH.
    • Investig Clin Urol. 2022 May;63(3):294-300. doi: 10.4111/icu.20220044.